STAT3-dependent cancer stem cell activation cervical cancer cell invasion and metastasis

Posted on by bm-jcc

 
crossMark
Journal of Cellular Cancer  Volume 6, Issue 2, pages 58-71
Published: December 22, 2014

Ming-Hua Yang, Hua Su, Liu Huang, Xiao-Hong Lee

Abstract

Cervical cancer is the most common cause of deaths due to any cancer in developing countries and the number of these is ten times that in developed countries. It is the third most common cancer in women after breast and colorectal cancer. Although the surgical skills and adjuvant chemotherapy have been improved, the survival rate of gastric cancer patients remains unsatisfactory. The aim of this study is to investigate the correlation between cervical cancer metastasis and activator of transcription-3 (STAT3) expression by immunohistochemical method and in situ hybridization to further demonstrate the mRNA expression of STAT3 in cervical cancer. Data from in vitro and in vivo studies on cervical cancer cells have revealed role of STAT3 to promote the survival and inhibit the apoptosis of cervical cancer cells.

Keywords: Stat 3; Cervical cancer; mRNA; Apoptosis

Purchase access to this articleReferencesExport Citation
Purchase this article at rate $55.00 and received Full-Text/PDF You will have online immediate access to article following the completion of this purchase and you may download and print a copy of each article for your personal use. Purchase Article

References

  1. Aggarwal P, Batra S, Gandhi G, Zutshi V. Can visual inspection with acetic acid under magnification substitute colposcopy in detecting cervical intra-epithelial neoplasia in low-resource settings?. Arch Gynecol Obstet 2011;284:397-403. [Abstract/Full-Text]
  2. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011;377:2085-2092. [PubMed]
  3. Miller AB, Nazeer S, Fonn S, Brandup-Lukanow A, et al. Report on consensus conference on cervical cancer screening and management. Int J Cancer 2000;86:440-447. [PubMed]
  4. Sahasrabuddhe VV, Luhn P, Wentzensen N. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol 2011;6:1083-1098. [PubMed]
  5. Scholz A, Heinze S, Detjen KM, et al. Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. Gastroenterology 2003;125:891-905. [PubMed]
  6. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000;19:2474-2488. [PubMed]
  7. Huang M, Page C, Reynolds RK, Lin J. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol Oncol 2000;79:67-73. [PubMed]
  8. Song JI, Grandis JR. STAT signaling in head and neck cancer. Oncogene 2000;19:2489-2495. [PubMed]
  9. Lee J, Kang WK, Park JO, et al. Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma. APMIS 2009;117:598-606. [PubMed]
  10. Aoki Y, Feldman GM, Tosato G. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 2003;101:1535-1542. [PubMed]
  11. Hebenstreit D, Horejs-Hoeck J, Duschl A. JAK/STAT-dependent gene regulation by cytokines. Drug News Perspect 2005;18:243-249. [PubMed]
  12. Akira S. Roles of STAT3 defined by tissue-specific gene targeting. Oncogene 2000;19:2607-2611. [PubMed]
  13. Gao B. Cytokines, STATs and liver disease. Cell Mol Immunol 2005;2:92-100. [PubMed]
  14. Mitchell TJ, John S. Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas. Immunology 2005;114:301-312. [PubMed]
  15. Gong W, Wang L, Yao JC, et al. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin Cancer Res 2005;11:1386-1393. [PubMed]
  16. Appleby P, Beral V, Berrington de González A, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007;370:1609-1621. [PubMed]
  17. Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, Ferlay J. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011;22:2675-2686. [PubMed]
  18. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1157-1164. [PubMed]
  19. Fisher JW, Brundage SI. The challenge of eliminating cervical cancer in the United States: a story of politics, prudishness, and prevention. Women Health 2009;49:246-261. [PubMed]
  20. Kjær SK, Frederiksen K, Munk C, Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 2010;102:1478-1488. [PubMed]
  21. Doshi WB, Thury PG, Chen R, Fishbein JA, Foley MK. Synergistic interaction between AKT and Notch-1 signaling in cervical cancer: a critical role in tumor cell migration and invasion. American Journal of BioMedicine 2014;2(2):200–211. [Abstract/Full-Text]

Journal of cellular cancer picture

 

 

 

 

 

 

Ming-Hua Yang, Hua Su, Liu Huang, Xiao-Hong Lee. STAT3-dependent cancer stem cell activation cervical cancer cell invasion and metastasis. Journal of cellular cancer 2014; 6(2):58-71.